1. Home
  2. NOVT vs NAMS Comparison

NOVT vs NAMS Comparison

Compare NOVT & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Novanta Inc.

NOVT

Novanta Inc.

HOLD

Current Price

$116.63

Market Cap

4.9B

Sector

Miscellaneous

ML Signal

HOLD

Logo NewAmsterdam Pharma Company N.V.

NAMS

NewAmsterdam Pharma Company N.V.

HOLD

Current Price

$28.58

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOVT
NAMS
Founded
1968
2019
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
3.5B
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
NOVT
NAMS
Price
$116.63
$28.58
Analyst Decision
Hold
Strong Buy
Analyst Count
1
8
Target Price
$133.00
$46.75
AVG Volume (30 Days)
391.1K
804.5K
Earning Date
05-26-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.47
N/A
Revenue
$521,290,000.00
N/A
Revenue This Year
$8.71
$25.64
Revenue Next Year
$6.47
$530.85
P/E Ratio
$81.06
N/A
Revenue Growth
35.49
N/A
52 Week Low
$98.27
$14.06
52 Week High
$149.95
$42.00

Technical Indicators

Market Signals
Indicator
NOVT
NAMS
Relative Strength Index (RSI) 32.18 34.30
Support Level $111.49 $23.48
Resistance Level $126.36 $37.43
Average True Range (ATR) 7.01 1.77
MACD -2.72 -0.42
Stochastic Oscillator 0.94 0.75

Price Performance

Historical Comparison
NOVT
NAMS

About NOVT Novanta Inc.

Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

Share on Social Networks: